Scholar Rock to Present at Cowen’s 42nd Annual Health Care Conference
February 25 2022 - 7:30AM
Business Wire
Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical
company focused on the treatment of serious diseases in which
protein growth factors play a fundamental role, today announced
that management will participate in an Orphan Neuro and
Neuromuscular panel discussion at Cowen’s 42nd Annual Health Care
Conference on Monday, March 7, 2022 at 9:10 a.m. ET.
A live webcast of the presentation may be accessed by visiting
the Investors & Media section of the Scholar Rock website at
http://investors.scholarrock.com. An archived replay of the webcast
will be available on the Company’s website for approximately 30
days following the presentation.
About Scholar Rock
Scholar Rock is a clinical-stage biopharmaceutical company
focused on the discovery and development of innovative medicines
for the treatment of serious diseases in which signaling by protein
growth factors plays a fundamental role. Scholar Rock is creating a
pipeline of novel product candidates with the potential to
transform the lives of patients suffering from a wide range of
serious diseases, including neuromuscular disorders, cancer, and
fibrosis. Scholar Rock’s approach to targeting the molecular
mechanisms of growth factor activation enabled it to develop a
proprietary platform for the discovery and development of
monoclonal antibodies that locally and selectively target these
signaling proteins at the cellular level. By developing product
candidates that act in the disease microenvironment, the Company
intends to avoid the historical challenges associated with
inhibiting growth factors for therapeutic effect. Scholar Rock
believes its focus on biologically validated growth factors may
facilitate a more efficient development path. For more information,
please visit www.ScholarRock.com or follow Scholar Rock on Twitter
(@ScholarRock) and LinkedIn
(https://www.linkedin.com/company/scholar-rock/).
Scholar Rock® is a registered trademark of Scholar Rock,
Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220225005011/en/
Scholar Rock Contact: Investors Rushmie Nofsinger
Scholar Rock rnofsinger@scholarrock.com 857-259-5573
Media Ariane Lovell Finn Partners
ariane.lovell@finnpartners.com 917-565-2204
Scholar Rock (NASDAQ:SRRK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Scholar Rock (NASDAQ:SRRK)
Historical Stock Chart
From Apr 2023 to Apr 2024
